Literature DB >> 10639315

Implication of the C-terminal domain of nef protein in the reversion to pathogenicity of attenuated SIVmacBK28-41 in macaques.

B A Lafont1, Y Rivière, L Gloeckler, C Beyer, B Hurtrel, M Paule Kieny, A Kirn, A M Aubertin.   

Abstract

We have analyzed the nef gene sequences amplified from 12 macaques presenting various patterns of infection with SIVmacBK28-41, a clone derived from attenuated SIVmacBK28. We have observed seven mutation hot spots at positions 56, 75, 432, 588, 680, 699, and 779. The major alteration was a thymidine insertion at position 699, leading to a frameshift in the SIVmacBK28-41 nef gene and changing the last 15 amino acids of Nef into a 31-amino-acid-long C-terminal domain nearly identical to that encoded by pathogenic SIVmac239 and SIVmac251. The insertion was found at early time points in proviruses obtained from rapid progressor macaques, after 2 years postinfection in progressors, and rarely or only after 4 years postinfection in nonprogressors. Fixation of the other mutations occurred only after insertion of thymidine 699. Phylogenetic analysis demonstrated that the nef genes isolated from progressors evolved from the allele present in SIVmacBK28-41 to alleles present in SIVmac239 or SIVmac251, whereas nef sequences from nonprogressors stayed clustered with that of the inoculated molecular clone. These data stress the importance of the C-terminal extremity of the Nef protein of SIVmac239 or SIVmac251 in viral pathogenesis. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10639315     DOI: 10.1006/viro.1999.9991

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  5 in total

1.  Simian and human immunodeficiency virus Nef proteins use different surfaces to downregulate class I major histocompatibility complex antigen expression.

Authors:  T Swigut; A J Iafrate; J Muench; F Kirchhoff; J Skowronski
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Persistence of pathogenic challenge virus in macaques protected by simian immunodeficiency virus SIVmacDeltanef.

Authors:  E Khatissian; V Monceaux; M C Cumont; M P Kieny; A M Aubertin; B Hurtrel
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  Efficient class I major histocompatibility complex down-regulation by simian immunodeficiency virus Nef is associated with a strong selective advantage in infected rhesus macaques.

Authors:  J Münch; N Stolte; D Fuchs; C Stahl-Hennig; F Kirchhoff
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

4.  Chimeric human immunodeficiency virus type 1 (HIV-1) virions containing HIV-2 or simian immunodeficiency virus Nef are resistant to cyclosporine treatment.

Authors:  Mahfuz Khan; Lingling Jin; Ming Bo Huang; Lesa Miles; Vincent C Bond; Michael D Powell
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

5.  Structure of HIV-2 Nef Reveals Features Distinct from HIV-1 Involved in Immune Regulation.

Authors:  Kengo Hirao; Sophie Andrews; Kimiko Kuroki; Hiroki Kusaka; Takashi Tadokoro; Shunsuke Kita; Toyoyuki Ose; Sarah L Rowland-Jones; Katsumi Maenaka
Journal:  iScience       Date:  2019-12-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.